Harrison R A, Bickle Q D, Kiare S, James E R, Andrews B J, Sturrock R F, Taylor M G, Webbe G
Department of Medical Parasitology, London School of Hygiene and Tropical Medicine, UK.
Trans R Soc Trop Med Hyg. 1990 Jan-Feb;84(1):89-99. doi: 10.1016/0035-9203(90)90393-s.
We have shown previously that baboons (Papio anubis) develop high levels (greater than 80%) of protection against challenge infection following immunization with Schistosoma haematobium cercariae irradiated with 20 krad. In the present study baboons were immunized with schistosomula irradiated with either 20 krad or 60 krad, with variations in the timing and number of larvae comprising each vaccination. Baboons immunized 2 or 3 times with schistosomula irradiated with 20 krad were significantly more protected (85-90%) against challenge infection than baboons similarly immunized with larvae receiving 60 krad (56-50% protection). Baboons immunized with schistosomula irradiated with 20 krad were better protected against challenge infection at 8 weeks after immunization than at 28 weeks after immunization. Protection was manifest by a reduction in worm numbers, tissue and excreta egg counts, gross pathology and, to a lesser extent, by stability of body weight and haematological indices following challenge. Enzyme-linked immunosorbent assay (ELISA) results of selected baboon sera showed few differences related to irradiation dose alone, but titres were higher in baboons receiving booster immunizations, and there was a significant correlation between titres immediately preceding challenge and the degree of resistance. Examination of responses to individual schistosomular surface antigens by immunoprecipitation and sodium dodecyl sulphate-polyacrylamide gel electrophoresis showed no correlation between the pattern of antigens recognized and resistance status. As with the ELISA assay, an anamnestic response was detected after vaccination, while the amount of antibody present declined markedly with increasing time after individual immunizations.
我们之前已经表明,用20千拉德照射的埃及血吸虫尾蚴免疫狒狒(阿拉伯狒狒)后,它们对攻击感染产生了高水平(超过80%)的保护。在本研究中,用20千拉德或60千拉德照射的血吸虫童虫免疫狒狒,每次疫苗接种的幼虫时间和数量有所不同。用20千拉德照射的血吸虫童虫免疫2次或3次的狒狒,比用60千拉德照射的幼虫进行类似免疫的狒狒对攻击感染的保护作用明显更强(85%-90%)(保护率为56%-50%)。用20千拉德照射的血吸虫童虫免疫的狒狒,在免疫后8周比免疫后28周对攻击感染的保护作用更好。保护表现为虫体数量减少、组织和排泄物中的虫卵计数减少、大体病理学变化减轻,在较小程度上还表现为攻击后体重和血液学指标的稳定。所选狒狒血清的酶联免疫吸附测定(ELISA)结果显示,仅与照射剂量相关的差异很少,但接受加强免疫的狒狒滴度更高,攻击前即刻的滴度与抵抗程度之间存在显著相关性。通过免疫沉淀和十二烷基硫酸钠-聚丙烯酰胺凝胶电泳检测对单个血吸虫童虫表面抗原的反应,结果显示所识别的抗原模式与抵抗状态之间没有相关性。与ELISA检测一样,接种疫苗后检测到了回忆反应,而每次免疫后随着时间的增加,存在的抗体量显著下降。